| | 107753-78-6 Basic information More.. |
| Product Name: | Zafirlukast | | Synonyms: | Carbamic acid, [3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester;Cyclopentyl 3-[2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl]-1-methylindole-5-carbamate;[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic acid cyclopentyl ester;4-[5-(Cyclopentyloxycarbonylamino)-1-methyl-1H-indol-3-ylmethyl]-3-methoxy-N-(2-methylphenylsulfonyl)benzamide;IC-204219;Carbamic acid, N-[3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester;cyclopentyl N-{3-[(2-Methoxy-4-{[(2-Methylbenzene)sulfonyl]carbaMoyl}phenyl)Methyl]-1-Methyl-1H-indol-5-yl}carbaMate;Cyclopentyl N-[3-{[2-Methoxy-4-[(2-Methylphenyl) sulfonylcarbaMoy | | CAS: | 107753-78-6 | | MF: | C31H33N3O6S | | MW: | 575.68 | | EINECS: | | | Mol File: | 107753-78-6.mol |  |
Use
Leukotrienes play an important role in the pathogenesis of asthma. These substances are peptides, being capable of selectively binding to LTC4, LTD4 and LTE4 receptor for antagonism of its effect, reducing the symptoms of asthma and improving lung function. This product is both a preventive agent of inflammation caused by asthma (being antagonistic to leukotriene proinflammatory activity) and a relief drug for bronchial asthma (be antagonistic to leukotriene induced bronchial smooth muscle contraction).
- Zafirlukast
-
- US $0.00 / G
- 2024-11-02
- CAS:107753-78-6
- Min. Order: 10G
- Purity: 98%min
- Supply Ability: 30KG/month
- Zafirlukast
-
- US $58.00-84.00 / mg
- 2024-10-31
- CAS:107753-78-6
- Min. Order:
- Purity: 99.31%
- Supply Ability: 10g
- Zafirlukast
-
- US $0.00 / g
- 2024-10-16
- CAS:107753-78-6
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
|
|
107753-78-6
Recommend Suppliers |
|